CIK: 0002104501
Total reported value
$281.2M
Reporting period: 2026-03-31 · Number of holdings: 6
Remedium Capital Partners, LLC disclosed 6 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $281.2M and a quarterly turnover rate of 51.1%.
Browse other institutions with $100M to $1B AUMBrowse other institutions starting with "R"
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Add DMRA
+1597.9% $50.2M
Trim APGE
0.0% $5.1M
Trim JBIO
0.0% -$2.2M
Trim SYRE
0.0% $25.7M
Trim ORKA
+0.9% $29.7M
Trim 38000Q201
0.0% $2.4M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ORKA | Oruka Therapeutics INC | Stock-Other | 27.31% | -0.33% | +0.85% | |
| 2 | SYRE | Spyre Therapeutics INC | Stock-Other | 26.13% | -1.90% | — | |
| 3 | DMRA | Damora Therapeutics INC | Stock-Other | 18.84% | +17.21% | +1597.87% | |
| 4 | APGE | Apogee Therapeutics INC | Stock-Other | 17.47% | -8.41% | — | |
| 5 | JBIO | Jade Biosciences INC | Stock-Other | 7.88% | -6.42% | — | |
| 6 | ✓ | Crescent Biopharma INC. | Stock-Other | 2.36% | -0.16% | — |
Performance for Q3 2026
+31.6%
Performance Last 4 Quarters
+102.6%
Based on 5 months of available history
Based on 51% of reported portfolio value with available pricing
Not enough sector-mapped data yet
Remedium Capital Partners, LLC's most significant position changes for 2026-03-31: Add: Damora Therapeutics INC (DMRA) — shares +1597.87%; Add: Oruka Therapeutics INC (ORKA) — shares +0.85%.
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | DMRA | Damora Therapeutics INC | +17.2% | +1597.87% | Add |
| 2 | ✓ | Crescent Biopharma INC. | -0.2% | — | Unchanged |
| 3 | ORKA | Oruka Therapeutics INC | -0.3% | +0.85% | Add |
| 4 | SYRE | Spyre Therapeutics INC | -1.9% | — | Unchanged |
| 5 | JBIO | Jade Biosciences INC | -6.4% | — | Unchanged |
| 6 | APGE | Apogee Therapeutics INC | -8.4% | — | Unchanged |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2026-03-31 | 2026-05-19 | Amendment | View on EDGAR |
| 2026-03-31 | 2026-05-13 | 13F-HR | View on EDGAR |
| 2025-12-31 | 2026-02-12 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001890435
Total reported value
$281.1M
35 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001598102
Total reported value
$281.2M
60 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001050068
Total reported value
$281.1M
152 stks
2026-03-31
AUM within 0.0% of this institution
Institutions with overlapping top holdings
CIK 0001615982
Total reported value
$2.7B
33 stks
2026-03-31
3 of the top 5 holdings overlap, including Apogee Therapeutics INC
CIK 0001802528
Total reported value
$1.4B
12 stks
2026-03-31
3 of the top 5 holdings overlap, including Damora Therapeutics INC
CIK 0001791827
Total reported value
$493.8M
45 stks
2026-03-31
2 of the top 5 holdings overlap, including Oruka Therapeutics INC